| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
491,390,000 |
| Market
Cap: |
8.45(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.08 - $17.2 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 11.5 |
| Insider 6 Months : 11.5 |
| Insider 3/6 Months : 23 |
|
| Guru Rank Number : 235 |
| Guru Rank Value : 5.2 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Elanco Animal Health is an animal health company. Co. groups its products into four principal categories: Companion Animal (CA) Disease Prevention, which includes parasiticides and vaccine products for canines and felines; CA Therapeutics, which includes products for the treatment of pain, osteoarthritis, otitis, cardiovascular and dermatology indications in canines and felines; Food Animal (FA) Future Protein and Health, which includes vaccines, antibiotics, parasiticides and other products used in poultry and aquaculture production; and FA Ruminants and Swine, which includes vaccines, antibiotics, implants, parasiticides and other products used in ruminants and swine production.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
38,100 |
38,100 |
38,100 |
147,300 |
| Total Buy Value |
$617,802 |
$617,802 |
$617,802 |
$2,195,450 |
| Total People Bought |
3 |
3 |
3 |
7 |
| Total Buy Transactions |
3 |
3 |
3 |
11 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bayer World Investments B.v. |
10% Owner |
– – • |
2020-12-03 |
4 |
S |
$29.84 |
$1,626,367,200 |
I/I |
(54,500,000) |
18,446,429 |
|
-3% |
|
| Anand Kapila K |
Director |
– • – |
2020-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,885 |
19,160 |
|
- |
|
| Mcdonald Kirk P |
Director |
– • – |
2020-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,885 |
13,901 |
|
- |
|
| Garcia Art A |
Director |
– • – |
2020-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,885 |
14,940 |
|
- |
|
| Kurzius Lawrence Erik |
Director |
– • – |
2020-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,885 |
26,960 |
|
- |
|
| Kochevar Deborah Turner |
Director |
– • – |
2020-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,885 |
14,901 |
|
- |
|
| Pollard-Knight Denise |
Director |
– • – |
2020-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,885 |
13,901 |
|
- |
|
| Hoover R David |
See Remarks |
– • – |
2020-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,885 |
41,960 |
|
- |
|
| Bilbrey John P |
Director |
– • – |
2020-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,885 |
13,901 |
|
- |
|
| Harrington Michael J |
Director |
– • – |
2020-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,885 |
22,684 |
|
- |
|
| Ehle Dirk |
Ex VP & Pres Elanco Europe |
• – – |
2020-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,188 |
9,188 |
|
- |
|
| Lee Joyce J. |
Ex VP Prs US Pet Hlth Com Op |
• – – |
2020-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
27,289 |
27,289 |
|
- |
|
| Meer James M |
Chief Accounting Officer |
• – – |
2020-10-01 |
4 |
D |
$27.53 |
$16,793 |
D/D |
(610) |
7,307 |
|
- |
|
| Schacht Aaron L |
See Remarks |
• – – |
2020-09-01 |
4 |
D |
$28.77 |
$121,841 |
D/D |
(4,235) |
62,492 |
|
- |
|
| Urbanek David Alan |
See Remarks |
• – – |
2020-09-01 |
4 |
D |
$28.77 |
$81,218 |
D/D |
(2,823) |
64,589 |
|
- |
|
| Hoover R David |
See Remarks |
– • – |
2020-08-28 |
4 |
B |
$28.62 |
$143,100 |
I/I |
5,000 |
45,000 |
2.1 |
8% |
|
| Hoover R David |
See Remarks |
– • – |
2020-08-27 |
4 |
B |
$28.24 |
$141,200 |
D/D |
5,000 |
36,075 |
2.39 |
12% |
|
| Hoover R David |
See Remarks |
– • – |
2020-08-21 |
4 |
B |
$26.94 |
$269,400 |
D/D |
10,000 |
31,075 |
2.39 |
13% |
|
| Bilbrey John P |
Director |
– • – |
2020-08-19 |
4 |
B |
$26.20 |
$250,996 |
I/I |
9,580 |
24,222 |
2.1 |
19% |
|
| Garcia Art A |
Director |
– • – |
2020-08-06 |
4 |
B |
$24.76 |
$49,520 |
D/D |
2,000 |
9,055 |
2.39 |
25% |
|
| Young Todd S. |
See Remarks |
• – – |
2020-08-03 |
4 |
B |
$23.85 |
$167,400 |
I/I |
7,000 |
5,000 |
1.99 |
23% |
|
| Bayer World Investments B.v. |
10% Owner |
– – • |
2020-08-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
72,946,429 |
|
23% |
|
| Mason Racquel Harris |
See Remarks |
• – – |
2020-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
21,237 |
21,237 |
|
- |
|
| Correia De Simas Jose Manuel |
See Remarks |
• – – |
2020-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,102 |
15,102 |
|
- |
|
| Meer James M |
Chief Accounting Officer |
• – – |
2020-06-03 |
4 |
D |
$22.93 |
$1,628 |
D/D |
(71) |
7,917 |
|
- |
|
390 Records found
|
|
Page 11 of 16 |
|
|
0.21 (1.24%) 
